Physician profile
Ryan P Bierle
NPI 1578849733
$1,366.94
in general payments reported to CMS, 2019-2025
12 companies · $286 in 2025
The $286 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $295 · 2022: $351 · 2023: $311 · 2024: $125 · 2025: $286.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $722.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $248.03 | 2024-2025 | Opsumit, Uptravi |
| Chiesi USA, INC. | $169.98 | 2022-2025 | Cleviprex |
| Grifols USA, LLC | $157.81 | 2021 | |
| Stryker Corporation | $152.54 | 2023 | Physio - Lucas |
| Astrazeneca Pharmaceuticals LP | $124.99 | 2022 | |
| Alexion Pharmaceuticals, INC. | $124.99 | 2021 | |
| La Jolla Pharmaceutical Company | $118.16 | 2022 | |
| Vapotherm INC | $100.61 | 2025 | Vapotherm |
| Fisher & Paykel Healthcare INC | $78.06 | 2023 | Fisher & Paykel Healthcare |
| Teleflex LLC | $63.79 | 2023 | Arrow |
| Brainscope Company, INC. | $16.20 | 2023 | Brainscope One |
| Ethicon US, LLC | $11.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bierle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.